The Pandemic Preparedness Paradox: Who Pays for Infrastructure That Might Never Be Needed?
Problem Definition
The world spent trillions responding to COVID-19, yet cannot agree to spend $5 billion annually to prevent the next pandemic.
This is a classic public goods problem: the benefits of pandemic preparedness are diffuse (everyone benefits from pandemic prevention) while the costs are concentrated (specific countries that invest in surveillance and manufacturing capacity bear the financial burden).
Individual countries have no financial incentive to invest in pandemic infrastructure that primarily benefits others. The result is a global undersupply of preparedness — every country is waiting for someone else to build the surveillance networks and manufacturing capacity.
Root Causes
Disease surveillance and pandemic response provide public goods that cannot be monetized — individual countries cannot capture the financial returns from investment
High-income countries that could afford preparedness investment have forgotten the 2020 crisis; political attention has shifted to other threats
Vaccine manufacturing is highly profitable during pandemics but unprofitable during preparation; private investment is minimal absent guaranteed demand
The pandemic preparedness goods are technical public goods (surveillance networks, diagnostic capacity) that require government coordination, not market solutions
Current financing mechanisms (GAVI, Global Health Fund) are donor-dependent and under-resourced relative to need